Brian Taylor Slingsby, Director, 10% Owner at Mineralys Therapeutics, Inc. (MLYS), sold 550,000 shares at $13.05 ($7.2M) on 2024-07-24, disclosed to the SEC on 2024-07-26.
Open-market sale of $7.2M MLYS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MLYS | BUY | 2023-02-16 | $4.0M | — | Filing → |